EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond treatment-associated signals: a clinical decision framework for biomarker-guided acupuncture in integrative psychiatry

Jinyong Moon, Seung-Nam Kim

Frontiers in Psychiatry · 17.11.2026 · 17

DOI: 10.3389/fpsyt.2026.2003116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 17.11.2026. Verfasst von Jinyong Moon und 1 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integrative psychiatry seeks to combine conventional care with evidence-based complementary interventions in ways that reflect clinical context and patient values. Acupuncture may contribute to this goal, but current biomarker research is frequently interpreted beyond what its design can support. A molecular feature that changes after acupuncture is not necessarily a pretreatment predictor, a causal mediator, or a clinically useful decision tool. We propose a clinical decision framework that assigns treatment-associated signals to four distinct functions: pretreatment selection, early trajectory monitoring, mechanistic triangulation, and decision-grade utility. Psychiatric biomarker studies provide precedents for treatment-by-biomarker interactions and longitudinal trajectory analyses, while acupuncture studies demonstrate treatment-associated circulating microRNA, protein, electroencephalographic, and functional-network signals. These findings establish biological plausibility but do not yet provide an externally validated molecular signature that selects psychiatric patients for acupuncture over a credible alternative. Using major depressive disorder as an illustrative application, we outline a comparator-inclusive, longitudinal, multicenter pathway that ties each biomarker function to a specified randomized contrast and a defined acupuncture protocol, with harmonized biospecimen procedures, prespecified modeling, locked external validation, and a final marker-guided utility trial. The framework treats biomarkers as aids to shared decision-making rather than biological gatekeepers. Its central claim is deliberately testable: biomarker-guided acupuncture becomes clinically meaningful only when a validated signature improves a treatment decision and that decision improves an outcome valued by patients.

Zitieren

APA

Moon, J., & Kim, S. (2026). Beyond treatment-associated signals: a clinical decision framework for biomarker-guided acupuncture in integrative psychiatry. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.2003116

Vancouver

Moon J, Kim S. Beyond treatment-associated signals: a clinical decision framework for biomarker-guided acupuncture in integrative psychiatry. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.2003116

BibTeX
@article{Moon2026,
  author = {Moon, Jinyong and Kim, Seung-Nam},
  title = {Beyond treatment-associated signals: a clinical decision framework for biomarker-guided acupuncture in integrative psychiatry},
  journal = {Frontiers in Psychiatry},
  year = {2026},
  volume = {17},
  doi = {10.3389/fpsyt.2026.2003116}
}
Kostenlos starten →